Acupoint Thread Embedding for Weight Loss: What a Sham-Controlled Trial in Annals of Internal Medicine Shows
Most acupuncture research asks whether a course of needling helps a condition. A new trial published in Annals of Internal Medicine asks a sharper question: what happens when the needle leaves something behind? Acupoint thread embedding — a traditional Chinese medicine technique in which a short piece of absorbable surgical thread is placed beneath the skin at an acupuncture point — is designed to keep stimulating the point for weeks after a single session, as the thread slowly dissolves.
That gap is what makes this study worth reading. It is a randomized, sham-controlled trial in 132 women, published online on November 17, 2026. Its headline result is neither a breakthrough nor a dismissal: modest weight loss, sustained for three months after treatment ended, with no change in blood sugar or cholesterol. The value of the trial lies less in the kilograms lost than in how carefully it was designed.
What They Did
The trial was conducted at the Acupuncture Department of Shanghai Municipal Hospital of Traditional Chinese Medicine. It enrolled 132 women aged 18 to 45 with a body mass index (BMI) of 24.0 kg/m² or higher — the threshold for overweight in Chinese guidelines — and randomly assigned them 1:1 to real thread embedding or a sham version. Both groups received six sessions over 12 weeks, followed by a further 12 weeks of follow-up.
The sham procedure is the part of the design that matters most. In the sham group, a needle was inserted superficially at the same acupuncture points, but without manipulation, without the characteristic deqi sensation of soreness or heaviness, without thread placement, and without needle retention. Participants, outcome assessors, and data analysts were all masked to group assignment; only the acupuncturists knew which treatment they were giving. The trial was registered prospectively on ClinicalTrials.gov (NCT06316310), and the primary outcome — change in BMI from baseline to week 12 — was analyzed under the intention-to-treat principle.
This is the methodological template that hands-on therapies need and rarely get. In a drug trial, a placebo pill can be made identical to the real one. In a needling trial, the control must reproduce the ritual — the visits, the lying still, the sensation of a needle — while removing the element under test. Here, the sham removed exactly one thing: the thread itself. Any difference between the groups can therefore be attributed, with reasonable confidence, to the thread and the prolonged stimulation it provides, rather than to attention, expectation, or the needle alone.
What They Found
At week 12, women who received real thread embedding had lost 1.8 kg more than women in the sham group (95% confidence interval, −2.7 to −0.9 kg), corresponding to a BMI difference of −0.7 kg/m² (95% CI, −1.0 to −0.3). By week 24 — three months after the last session — the gap had widened rather than faded: 3.0 kg more weight lost (95% CI, −4.5 to −1.6 kg) and a BMI difference of −1.1 kg/m² (95% CI, −1.7 to −0.6).
The proportion reaching a clinically meaningful threshold tells the same story in more human terms. At 12 weeks, 25.8% of women in the treatment group had lost at least 5% of their body weight, compared with 9.1% in the sham group — a risk difference of 16.7 percentage points (95% CI, 3.7 to 29.3). The treatment group also showed greater reductions in waist and hip circumference, body fat percentage, and appetite scores.
But the trial is equally honest about what did not change. Measures of cardiometabolic health — blood sugar and cholesterol — did not differ between the groups, and neither did patient-reported outcomes. Adverse events were mild and similarly distributed in both groups, with no serious safety concerns reported. That combination — a real but modest effect on weight, no detectable effect on metabolic markers — is exactly the pattern a careful reader should expect from a single, well-run trial of a low-intensity intervention, and the pattern most likely to be distorted by headlines, in either direction.
Why the Effect Size Needs Context
Three kilograms over six months deserves a sense of scale. Structured diet and exercise programs typically produce larger average losses, and modern anti-obesity medications substantially larger ones — but with daily dosing, higher costs, and side-effect profiles of their own. Thread embedding's appeal, if the effect holds up, is different: six clinic visits in three months, no daily medication, and an effect that persisted — even grew — for three months after treatment stopped.
The widening gap between week 12 and week 24 is the most intriguing part of the result, and also the part that most needs replication. In most weight-loss interventions, the largest difference appears during active treatment and then narrows as weight is regained. Here the difference grew. One plausible explanation is the mechanism the technique is built on — the thread dissolving over weeks, providing prolonged stimulation. Another is that appetite scores fell more in the treatment group, and a sustained reduction in appetite could keep weight drifting down after the sessions ended. Either way, a single trial cannot settle which explanation is right.
The 5%-threshold figure also deserves a second look. Losing 5% of body weight is the conventional marker of clinically meaningful weight loss, and the gap between 25.8% and 9.1% looks impressive. But turn the numbers around: roughly three in four women in the treatment group did not reach that threshold at 12 weeks. The honest summary is that thread embedding helped a minority lose a meaningful amount, and helped the average participant lose a modest amount.
What This Study Shows — and What It Cannot
Strengths. Prospective registration, a sham control matched for visit frequency and needling ritual, masking of participants, assessors, and analysts, an intention-to-treat analysis, and follow-up extending 12 weeks beyond treatment — this is a strong design by the standards of acupuncture research, and its publication in Annals of Internal Medicine signals that the field's methodological bar is rising.
Limitations. The authors state them plainly, and they matter. First, the trial was conducted at a single center, in one city, in one country. Patient expectations of acupuncture — and therefore the size of any context effect — may differ where the therapy is less familiar. Second, the participants were generally healthy women of reproductive age. The results say nothing directly about men, older adults, or people with significant medical conditions. Third, the acupuncturists could not be blinded, and participants may have guessed their assignment from the sensations of treatment — the deqi feeling that the sham deliberately omitted. That is a structural limit of needling trials, not a flaw in this one, but it means expectation effects cannot be fully excluded. Finally, follow-up ended at 24 weeks. Whether the weight stays off at one year or two is unknown, and the trial was underpowered for uncommon adverse events and subgroup analyses — it can say the treatment looked safe in 132 women over six months, not that it is safe for everyone.
The Practical Reading
For a reader considering thread embedding for weight management, the honest summary is this: in one well-designed trial, six sessions over 12 weeks produced an average of about 3 kg more weight loss than a matched sham procedure, with the difference still present three months after treatment ended, and with only mild side effects. Blood sugar and cholesterol did not improve, and most participants did not reach the 5% weight-loss threshold. That justifies a conversation with a qualified practitioner — and a clear-eyed comparison with diet, exercise, and other options — not a guarantee.
One safety note belongs in any article on this topic: thread embedding places a foreign material under the skin, and should only be performed by a trained, licensed practitioner using sterile technique. Anyone with a bleeding disorder, a skin infection at the treatment site, or a known sensitivity to the thread material should discuss those factors with a clinician first.
The deeper lesson is about evidence itself. For years, the evidence for thread embedding consisted mainly of small, unblinded studies and meta-analyses of those studies — the kind of literature that can make almost anything look effective. This trial replaces that with a cleaner question: compared with a procedure designed to feel like treatment, does leaving a thread behind do more, and does the difference last? On that question, for this population, the answer this time was yes — modestly, and durably enough to be worth following up. The next question is whether other teams, in other places, find the same thing.
Source: Xu S, et al. "Acupoint Thread Embedding for Weight Loss in Women with Overweight or Obesity: A Randomized Controlled Trial." Annals of Internal Medicine. Published online November 17, 2026. DOI: 10.7326/ANNALS-26-02294. Trial registration: NCT06316310.
If you are interested in how the classical Chinese medical tradition thinks about health more broadly — its ideas of balance, prevention, and the body's patterns — our book Huangdi Neijing: A Modern Introduction offers a beginner-friendly guide to the foundational text of TCM. For a grounding in the technique this trial builds on, see our beginner's guide to acupuncture.
This article is for educational purposes only and is not medical advice. If you are considering any treatment for weight management, please consult a qualified healthcare professional.